The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Yahoo! Finance Canada
Investing in fundamentally strong stocks that are flying under the radar should enable you to generate market-beating returns over time. One of the best Canadian stocks that you may not have heard of is AbCellera Biologics NASDAQ: ABCL), which trades on a U.S. exchange. Valued at a market cap of US$1.17 billion, ABCL stock went public in late 2020 and currently trades almost 94% from all-time highs. AbCellera Biologics discovers and develops antibody-based medicines for unmet medical needs using its proprietary antibody discovery platform. The Vancouver-based company's pipeline includes ABCL635 for metabolic and endocrine conditions, as well as ABCL575 for autoimmune disorders such as atopic dermatitis. AbCellera maintains strategic research collaborations and licensing partnerships with major pharmaceutical companies, including Eli Lilly Biogen, and Viking Global Investors. Is this Canadian stock a good buy right now? AbCellera Biologics reported third-quarter results, whi
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]Yahoo! Finance
- AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]Yahoo! Finance
- Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]Yahoo! Finance
- AbCellera Appoints Dr. Stephen Quake to its Board of DirectorsBusiness Wire
- Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]Yahoo! Finance
ABCL
Earnings
- 11/6/25 - Miss
ABCL
Sec Filings
- 11/28/25 - Form 8-K
- 11/26/25 - Form 4
- 11/12/25 - Form 8-K
- ABCL's page on the SEC website